Effectiveness of the booster dose of COVID-19 vaccine in the Basque Country during the sixth wave: A nationwide cohort study

被引:0
|
作者
Arrospide, A. [1 ,2 ]
Sagardui, M. G. [1 ]
Larizgoitia, I. [1 ]
Iturralde, A. [1 ,3 ]
Moreda, A. [1 ]
Mar, J. [2 ,4 ,5 ]
机构
[1] Minist Hlth Basque Govt, Donostia San Sebastian Kalea 1, Vitoria 01010, Spain
[2] Biodonostia Hlth Res Inst, Econ Evaluat Chron Dis Res Grp, San Sebastian, Spain
[3] Osakidetza Basque Hlth Serv, Directorate Gen, Vitoria, Spain
[4] Debagoiena Integrated Hlth Org, Osakidetza Basque Hlth Serv, Arrasate Mondragon, Spain
[5] Kronikgune Inst Hlth Serv Res, Baracaldo, Spain
关键词
COVID-19; Vaccine; Vaccine booster; Effectiveness; Hospital admissions; Omicron; IMPACT;
D O I
10.1016/j.vaccine.2023.05.061
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim of the study was to assess the effect of a booster dose of COVID-19 vaccine on the rates of hospital ward and intensive care unit (ICU) admissions around the time of emergence of the Omicron variant in the Basque Country. A retrospective cohort population-based study was conducted. The population with any records related to COVID-19 vaccination up to 28 February 2022 was classified into four cohorts by vaccination status. For every cohort, the hospital ward and ICU admission rates were calculated for each day between November 2021 and February 2022. Generalized linear models with a negative binomial distribution were used to estimate the age-adjusted hospitalization rate ratio of the cohort of individuals who had received a booster compared to the other cohorts. The age-adjusted rates of hospital ward and ICU admissions were 70.4 % and 72.0 % lower, respectively, in the fully vaccinated plus booster group compared to the fully vaccinated but no booster group. Analysing changes in the 14-day admission incidence rates showed that as the prevalence of the Omicron variant increased, the corresponding rate ratios decreased. The immunity acquired with the booster dose allowed the hospital network to meet all the demand for hospitalization during a period of high incidence of COVID-19, despite the fact that vaccine protection decreased as the prevalence of the Omicron variant increased. (c) 2023 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4274 / 4279
页数:6
相关论文
共 50 条
  • [1] Relative effectiveness of a heterologous booster dose with adenovirus type 5 vectored COVID-19 vaccine versus three doses of inactivated COVID-19 vaccine in adults during a nationwide outbreak of omicron predominance, in China: a retrospective, individually matched cohort-control study
    Jia, Siyue
    Yin, Zundong
    Pan, Hongxing
    Wang, Fuzhen
    Liu, Xiaoqiang
    Wang, Qing
    Zhang, Li
    Tang, Jihai
    Yang, Hao
    Du, Jiangbo
    Wang, Zhiguo
    Jin, Pengfei
    Peng, Zhihang
    Tang, Rong
    Kang, Guodong
    Wang, Xuewen
    Li, Simin
    Wang, Weixiao
    Li, Jingxin
    Shen, Hongbing
    Zhu, Fengcai
    EMERGING MICROBES & INFECTIONS, 2024, 13 (01)
  • [2] Why promoting a COVID-19 vaccine booster dose?
    Loubet, Paul
    Laureillard, Didier
    Martin, Aurelie
    Larcher, Romaric
    Sotto, Albert
    ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 2021, 40 (06)
  • [3] Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
    Rzymski, Piotr
    Poniedzialek, Barbara
    Fal, Andrzej
    VACCINES, 2021, 9 (11)
  • [4] Assessing the acceptability of COVID-19 vaccine and its booster dose
    Mubarak, Sawsan
    A'aqoulah, Ashraf
    AlGhawrie, Hadeel
    Albalas, Samir
    Innab, Nisreen
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (09)
  • [5] The pros and cons of the second booster dose of the COVID-19 vaccine
    Mostafavi, Ehsan
    IRANIAN JOURNAL OF MICROBIOLOGY, 2022, 14 (04) : 435 - 437
  • [6] Effectiveness of the Original COVID-19 Vaccine against COVID-19 Exacerbations during the Omicron Wave: A Population-based Study in Okayama, Japan
    Matsumoto, Naomi
    Mitsuhashi, Toshiharu
    Matsuo, Rumi
    Kadowaki, Tomoka
    Takao, Soshi
    Yorifuji, Takashi
    JMA JOURNAL, 2023, 6 (04): : 463 - 469
  • [7] COVID-19 Vaccine Booster Dose Acceptance among Older Adults
    Sezerol, Mehmet Akif
    Davun, Selin
    VACCINES, 2023, 11 (03)
  • [8] Willingness of Saudi Adults to Receive a COVID-19 Vaccine Booster Dose
    Alshahrani, Najim Z. Z.
    Ridda, Iman
    Rashid, Harunor
    Alzahrani, Faris
    Othman, Lujain Mohammed Bin
    Alzaydani, Hassan Ali
    SUSTAINABILITY, 2023, 15 (02)
  • [9] Risk factors for COVID-19 hospitalisation after booster vaccination during the Omicron period: A French nationwide cohort study
    Turpin, Agathe
    Semenzato, Laura
    Le Vu, Stephane
    Jabagi, Marie-Joelle
    Bouillon, Kim
    Drouin, Jerome
    Bertrand, Marion
    Kanagaratnam, Lukshe
    Weill, Alain
    Dray-Spira, Rosemary
    Zureik, Mahmoud
    Botton, Jeremie
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2024, 17 (07)
  • [10] Effectiveness of the Booster Dose in Protecting against COVID-19, Colombia 2022
    Galvez, Jubby Marcela
    Pinzon-Rondon, Angela Maria
    Chaparro-Solano, Henry Mauricio
    Tovar-Romero, Hanna Valentina
    Ramirez-Prieto, Juliana
    Ortigoza-Espitia, Sergio Andres
    Ruiz-Sternberg, Angela Maria
    VACCINES, 2023, 11 (09)